IVQ successfully grows liver cancer organoids
Invitrocue further validates its Onco-PDO technology platform through the successful growth of 14 liver cancer organoids
Invitrocue further validates its Onco-PDO technology platform through the successful growth of 14 liver cancer organoids
Escrow Release
Cleansing Statement
Appendix 3B – New issue announcement, application for quotation of additonal securities and agreement
Proposed Issue of Securities
Results of Annual General Meeting
2017 AGM Presentation
Cleansing Statement
Appendix 3B – New issue announcement, application for quotation of additonal securities and agreement
Proposed issue of securities